Layla Malt

Dr Layla Malt leads the Scientific Affairs and Behavioural Sciences function within the Harm Reduction and Engagement department at Imperial Brands. Over the past eight years, she has held a variety of roles within the organisation and now oversees a multidisciplinary team that informs the business on emerging scientific developments and generates the behavioural science evidence to substantiate the tobacco harm reduction potential of Imperial Brands next generation products. Her work plays a central role in Imperial Brands’ Scientific Assessment Framework. Dr Malt is a strong advocate for science-led dialogue, ensuring that robust evidence underpins meaningful interaction with key stakeholders. She began her career in academia and spent time in the pharmaceutical sector, gaining a broad scientific perspective before joining Imperial Brands. She holds a BSc in Biological Sciences and a PhD in Biochemistry from the University of Bristol.